BridgeBio Oncology to go public in $450M+ SPAC deal

The latest stories trending on MedCity News.

Editor's Pick

Top Story BridgeBio Oncology to Go Public in SPAC Deal Bringing $450M+ for Trio of Cancer Drugs Clinical-stage BridgeBio Oncology Therapeutics, whose financial backers include Cormorant Asset Management, is going public by merging with a Cormorant-sponsored SPAC. The combined company will continue developing drugs targeting various forms of mutated KRAS proteins that drive cancers. Sponsored Unlocking AI Potential: Navigating Data Risks and Rewards. Presented by symplr and MedCity News CEO BJ Schaknowski of symplr sits down with Katie Adams to discuss how healthcare consolidation drives the need for standardizing care delivery. This often involves simplifying the use of thousands of disparate applications. Learn more about how symplr is making healthcare less complex and more efficient. View It Now! Check out who is coming to INVEST 2025 in Chicago, this May 20 & 21, 2025! There's one important company missing from this list: Yours! This is your opportunity to network with like-minded professionals, build connections, and explore new collaborations in a relaxed and engaging environment.  Register For INVEST Chicago Now & Save $345

Featured News

Healthcare Moves: A Monthly Summary of Hires, Exits and Layoffs February has seen a slew of executive hires, exits and layoffs across the healthcare industry. For example, health tech companies like Cadence and Bamboo Health hired new C-suite leaders, and providers like Mass General Brigham and Corewell Health announced rounds of job cuts. MedCity Pivot Podcast: Being Clear About Cybersecurity A conversation with David Bardan, the general manager of the healthcare business at Clear, shows how the company is bringing its expertise to counter cybersecurity threats in the healthcare industry. MedCity FemFwd: Why Infertility Isn't Just a Women's Issue In this episode, we're joined by Pam Pure, co-founder and CEO of Posterity Health, and Khaled Kteily, founder and CEO of Legacy. They discuss why we should view infertility as a men's issue as well as a women's issue. Tia Teams Up with Nourish to Provide Nutrition Support to Women Through a partnership with Nourish, Tia's members will have access to virtual personalized nutrition guidance that can address a range of needs, such as hormonal balance, fertility, chronic disease management and weight management. Health Economics and Outcomes Research: Biopharma's Underappreciated Value Creator The way ahead for HEOR in biopharma should be built on increasing C-suite visibility and understanding of the value contribution that HEOR makes and demonstrating that a failure to invest in HEOR puts companies at a competitive disadvantage, especially in the face of rising regulatory and payer expectations for evidence. Biocompatible Nanoparticles: Tiny Antennae with Huge Potential for Brain-Computer Interfaces To bridge the gap between invasive and non-invasive technologies, nanoscale materials, such as biocompatible nanoparticles, provide a promising alternative, allowing us to design materials at the scale of cellular systems and structures.

Resources

sponsored New for 2025 Telemedicine Pricing Guide - Software Advice for Healthcare Presented by MedCity News How do you know if you're spending too much or too little on Telemedicine software? This guide from Software Advice breaks down upfront, subscription and hidden costs, plus answers other questions you've been wondering about. Gain Access Now

MedCity News • PO Box 901 • New York, NY unsubscribe